OncoTherapy Science (4564) Cash flow

Compare

2 Followers

OncoTherapy Science Cash Flow

JP:4564's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, JP:4564's free cash flow was decreased by ¥415.32M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Cash Flow	Mar 25	Mar 24	Mar 22	Mar 21	Mar 21
Operating Cash Flow	¥ -815.02M	¥ -1.23B	¥ -794.90M	¥ -1.76B	¥ -2.07B
Investing Cash Flow	¥ -279.00K	¥ -33.35M	¥ -20.32M	¥ -52.23M	¥ -467.93M
Financing Cash Flow	¥ 1.12B	¥ 671.37M	¥ 95.95M	¥ 0.00	¥ 1.48B
End Cash Position	¥ 833.88M	¥ 527.66M	¥ 1.12B	¥ 2.90B	¥ 1.84B
Free Cash Flow	¥ -815.30M	¥ -1.23B	¥ -800.29M	¥ -1.81B	¥ -2.53B

Currency in JPY